The British government announced on Monday that AustralianSuper, a pension giant, is planning to invest an additional 8 billion pounds ($10.15 billion) in the UK, bringing its total investment in the country to over 18 billion pounds. This significant investment comes at a pivotal time for the UK biotech sector, which saw a remarkable 94% increase in funding to £3.5 billion in 2024 compared to the previous year. The Chancellor’s recent decision to eliminate the pensions ‘lifetime allowance’ has also been welcomed as a positive development for the industry.
While the UK’s life sciences and biotech sector already boasts strong early-stage academic research, there is a growing need to support and nurture its thriving ecosystem. The International Investment Summit has put forth a package of recommendations aimed at boosting economic growth and innovation in the sector. Tokyo-based Beyond Next Ventures Inc. has also announced a substantial increase in its startup fund, signaling growing interest and confidence in the biotech industry. With AustralianSuper’s significant investment and the overall positive momentum in the UK biotech sector, there are promising prospects for further growth and development in the field.
Read more on news.search.yahoo.com